Canadian Cyclist DOrnellas Job Jan 13 24/7-1
   Follow us on Twitter
 
Find us on Facebook
 
The 11 inc Jan 5
 
Cyclist's Edge - November 15
 
TAg Nov 24 (+225)
 
Flow Coaching December 18
 
Share the Road - Dec 14
 

 
IMBA Canada - Dec 14
 

 
Tremblant CC-1 Jan30
 

Daily News


 

February 11/08 5:32 am - Banned Hair Loss Drug Can Lead to Sanctions


Posted by Editor on 02/11/08
 

Banned Hair Loss Drug Can Lead to Sanctions
Courtesy CCES

The Canadian Centre for Ethics in Sport (CCES) would like to warn athletes to avoid the use of finasteride, a prohibited substance which is currently sold in Canada under the brand names Propecia and Proscar. Commonly used to treat hair loss in men, finasteride has led to two doping violations in Canada and the United States in the last three years. The CCES strongly recommends that athletes subject to doping control do not take finasteride, as it will result in an anti-doping rule violation.

This substance has been on the World Anti-Doping Agency (WADA) Prohibited List since January 1, 2005. It is prohibited under the category S5, Diuretics and Other Masking Agents. Finasteride can be a masking agent, as its presence can interfere with sample analysis.

Starting with the 2008 version of the Prohibited List, finasteride is also a "specified substance." This classification recognizes that finasteride is particularly susceptible to an unintentional anti-doping rule violation because of its general availability in medicinal products. A violation involving a "specified substance" may result in a reduced sanction if an athlete can establish that its use was not intended to enhance sport performance.

To date, the CCES has never approved a therapeutic use exemption (TUE) for finasteride. The Canadian Anti-Doping Program states that, for a TUE to be granted, "the athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method were to be withheld in the course of treating an acute or chronic medical condition." This condition has never been satisfactorily met as finasteride is generally prescribed for aesthetic purposes.

Again, the CCES strongly recommends that athletes subject to doping control do not take finasteride, as it will result in an anti-doping rule violation.

Related reading:

* Canadian Centre for Ethics in Sport finasteride case - www.cces.ca/pdfs/CCES-MR-ViolationTheodore-E.pdf

* United States Anti-Doping Agency finasteride case - www.wada-ama.org/rtecontent/document/CASELAW_Lund.pdf

 


Return to Canadian Cyclist homepage | Back to Top
Jakroo Main Jan4 - GP
 
DOrnellas Overhaul Jan 13
 
WoB Save Sale Jan29
 
CC Advertise April 14
 
TO Bike Show 2016 Jan25
 

 
Dundas Speed Shop - Jan 11 (+524)
 
  


 
 © Copyright 1998-2016 Canadian Cyclist. All rights reserved.  Privacy Policy | Contact | Subscribe to RSS Feed  | Login